FDA Asks Drugs With Drospirenone To Carry Safety Label

Thursday, April 12th, 2012

The Food and Drug Administration (FDA) has said that oral contraceptives that contain drospirenone must add new labels stating a chance of a threefold increase in the risk of developing blood clots. This label change would be necessary for nine companies that produce oral contraceptives- Zarah, Yaz, Beyaz, Loryna, Gianvi, Yasmin, Ocella, Syeda and Safyral. […]